Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.62 -0.24 (-1.62%)
At close: Oct 21, 2026 · 4:00 PM EDT

Iovance Biotherapeutics (IOVA) Acquisitions (2023)

Updated

Iovance Biotherapeutics' Acquisitions came in at -$253,000 for Q4 2023.

Analysis

Iovance Biotherapeutics (IOVA) Acquisitions (2023) Analysis & Trends

For FY2023, Iovance Biotherapeutics' Acquisitions was $212.63 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -17.24 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.21 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Iovance Biotherapeutics 6.61 Bn 5.40 Bn 55.72 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -253,000.00
Sep 30, 2023 3.38 Mn
API Access

Iovance Biotherapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=IOVA&period=max&api_key=YOUR_API_KEY